Mira Pharmaceuticals, Inc. $MIRA

By Microcap Ledger desk · CIK 0001904286

Facts as of Oct 11, 2026, 08:14 AM UTC. Built from SEC filings and our own data. Small caps move fast; check the latest filings.

This page is still filling in. We publish more sections as filings are processed.

Snapshot

Exchange: Nasdaq Capital Market
Sector: Pharmaceutical Preparations
Headquarters: Miami, FL
Shares outstanding: 42,022,087 [10-Q 2026-08-12]
as of 2026-08-10

Sources: [10-K 2026-03-31]

Financial health

From XBRL company facts (USD)
Period	Revenue	Net income	Operating cash flow	Cash	Filing
6 months to Jun 2026	—	−$2.36M	−$2.41M	$3.61M	[10-Q 2026-08-12]
FY ended Dec 2025	—	−$10.44M	−$4.66M	$6.35M	[10-K 2026-03-31]
FY ended Dec 2024	—	−$7.85M	−$5.56M	$2.83M	[10-K 2026-03-31]

Quarterly cash burn: −$1.20M
Cash runway Estimate: ~9 months

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
Date	Shares outstanding	Filing
2024-11-13	14,780,885	[10-Q 2024-05-13]
2025-03-28	16,813,654	[10-K/A 2025-04-17]
2025-05-14	16,919,623	[10-Q 2025-05-14]
2025-08-13	19,069,315	[10-Q 2025-08-14]
2025-11-11	41,876,087	[10-Q 2025-11-13]
2026-03-30	42,022,087	[10-K 2026-03-31]
2026-05-14	42,022,087	[10-Q 2026-05-14]
2026-08-10	42,022,087	[10-Q 2026-08-12]

Shelf registration: S-3 filed 2024-08-12; declared effective 2024-08-16 [S-3 2024-08-12]

Listing status

Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-31. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

Date	Event	Details	Deadline	Filing
2026-07-31	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2026-07-31]
2025-04-11	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2025-04-11]

More on deficiency notices and uplistings: Listing status desk.

Catalysts and calendar

Recent filings and releases
Date	Type	Title
2026-09-17	8-K	Regulation FD disclosure
2026-09-16	8-K	Shareholder vote results
2026-09-01	8-K	Regulation FD disclosure
2026-08-12	10-Q	Quarterly report
2026-08-06	8-K	Regulation FD disclosure
2026-07-31	8-K	Listing notice or transfer
2026-07-28	DEF 14A	Proxy statement
2026-07-10	8-K	Regulation FD disclosure
2026-07-06	8-K	Regulation FD disclosure
2026-06-25	8-K	Regulation FD disclosure
2026-06-17	8-K	Regulation FD disclosure
2026-06-08	8-K	Director or officer change

Facts as of Oct 11, 2026, 08:14 AM UTC. Small caps move fast; check the latest filings.